Evolving Clinical Paradigms for LDL Lowering: Focus on Efficacy, Implications, Side Effects, and Safety Results of Clinical Trials Evaluating PCSK9 Inhibition—Implications for the Patient with Diabetes - James M. McKenney, PharmD